by Jean Bedard, CEO, Circulo Pharma
The Invisible Half of Pharma Sampling
Most pharma teams believe they have sampling under control.
They’ve invested heavily in CRM systems. Reps are trained. Requests are captured cleanly. Dashboards show activity. On the surface, everything looks optimized.
But that’s only the front end.
The moment a rep clicks “submit,” the real process begins, and it’s the part almost no one fully sees.
Sampling is not a transaction. It’s a multi-vendor operational chain involving CRM systems, compliance tools, third-party logistics providers, and often separate marketing fulfillment vendors. Each handoff introduces risk. Each system introduces interpretation. Each delay introduces exposure.
Yet most organizations operate as if everything after the request is automatic, controlled, and compliant by default.
It isn’t.
How Sample Requests Should Work
In a controlled environment, sampling operates as a single, orchestrated workflow rather than a series of disconnected steps.
A rep submits a request in the CRM, and that request is validated immediately in real time. Eligibility checks have either been preapproved or happen instantly. License status, sampling limits, territory rules, and compliance thresholds are verified before anything moves forward.
Once validated, the request flows seamlessly to the 3PL with complete and consistent data. There is no reinterpretation, no transformation, and no manual intervention.
Every step is tracked. Every decision is logged. Every data point has a clear lineage.
Compliance is not a checkpoint layered on top of the process. It is embedded into the process itself.
The outcome is a true closed-loop system where organizations have full traceability from request to delivery, real-time visibility across stakeholders, and audit-ready data that does not need to be reconstructed after the fact. There is no ambiguity about what happened, when it happened, or why.
How It Actually Works Today
In reality, most organizations operate very differently.
The CRM captures the request, but that is where centralized control effectively ends.
From there, the process begins to fragment. Data is exported or transferred to a compliance tool, where checks may happen immediately, later, or in parallel. In some cases, they are applied after fulfillment has already started.
The 3PL receives the order with limited context and executes based on the data provided, not necessarily the data that was originally validated.
Marketing materials are handled separately, often through entirely different systems with their own workflows and rules. There is little to no coordination between these streams.
Reporting is assembled after the fact. Teams pull data from multiple systems, reconcile inconsistencies manually, and attempt to create a coherent picture of what occurred.
What appears seamless at a high level is, in practice, a chain of disconnected systems held together by assumptions and manual effort. The result is delayed visibility, multiple points of data vulnerability, and no single system accountable for the full lifecycle.
The Hidden Gaps No One Talks About
These challenges are not new. What has changed is how exposed they have become under increased scrutiny.
Vendor Handoff Risk
Every transition between systems introduces a point of failure. Data moves from CRM to compliance tools to 3PLs, and at each step, it can be transformed, mapped, or manually adjusted.
No single system owns the integrity of that data across the entire lifecycle.
When something goes wrong, each vendor can demonstrate that their system functioned correctly. What no one can prove is that the data remained consistent from start to finish.
This creates real exposure. Records can become inconsistent, data can be lost or altered, and during an audit, there is no defensible lineage to fall back on.
Compliance Timing Gaps
Compliance is often assumed to be built into the process, but in many cases, it is applied after the fact.
Checks may occur after a request is submitted or even after fulfillment has begun. That creates a window where samples can move forward before full validation is complete.
When issues are identified, they are corrected retroactively. But regulators don’t evaluate intent. They evaluate whether compliance existed at the moment of action.
This creates risk that is not always visible internally but is very visible externally.
Audit Blind Spots
Most audits focus on what is easy to verify, such as sample counts, signatures, and basic documentation.
What they often miss is the underlying integrity of the process.
Few organizations can clearly demonstrate when compliance checks occurred relative to shipment, which version of HCP data was used at the time of approval, or how exceptions were handled across systems.
An audit can be passed without proving that the process itself is sound. That creates a dangerous gap between perceived compliance and actual compliance.
Multi-Vendor Reporting Gaps
Data is fragmented across systems. CRM holds request data, 3PLs hold fulfillment data, compliance tools hold validation data, and marketing platforms track engagement.
To build a complete view, teams must pull and reconcile data manually.
This introduces delays, inconsistencies, and interpretation errors. By the time reporting is complete, the information is already outdated.
Without a single source of truth, organizations are making decisions based on incomplete or misaligned data.
Marketing and Sample Workflow Disconnect
Sampling is not an isolated activity. It is part of a broader HCP engagement strategy.
But in most organizations, samples and marketing materials are managed separately. Different systems, different workflows, and different visibility.
There is no unified view of what an HCP is receiving across both streams.
This leads to inconsistent experiences, misalignment between promotional and sampling activity, and missed compliance considerations across combined interactions.
Why These Gaps Exist
These gaps are not the result of poor execution. They are the result of how the ecosystem has been built.
Pharma organizations rely on multiple specialized systems, each designed to solve a specific part of the problem. CRM captures requests. Compliance tools validate. 3PLs fulfill. Marketing systems manage materials.
Each system performs its function well, but none of them own the end-to-end workflow.
There is an assumption that these systems will connect cleanly and remain aligned.
They do not.
There is also a common misconception that CRM serves as the system of record for the entire process. In reality, CRM captures intent, not execution.
What is missing is a central layer that orchestrates how these systems interact, how data flows between them, and how compliance is enforced throughout the lifecycle.
The Risk Landscape
This is no longer just an operational inefficiency. It is a growing strategic risk.
Regulatory scrutiny in Canada is increasing, and expectations around real-time compliance and audit readiness continue to rise.
At the same time, vendor ecosystems are becoming more complex. More systems mean more integrations, and more integrations mean more opportunities for misalignment.
The risk is not a single point of failure.
It is the accumulation of small gaps across the lifecycle that creates systemic ambiguity.
When no single system owns the process, no organization can fully prove that it is compliant from start to finish.
That is where exposure begins.
The Circulo Model
The Circulo Pharma Management Platform is built to address this exact problem.
It sits between CRM and 3PL as the operational and compliance orchestration layer, controlling how data moves and how workflows are executed.
At the point of request, Circulo enforces compliance in real time, using pre-configured eligibility rules so that only valid requests can proceed.
From there, it orchestrates the workflow across all vendors, ensuring that each system receives consistent, validated data.
Every step is tracked. Every decision is logged. Every data point is preserved with full lineage.
The result is a single, unified source of truth for both operational and compliance data.
Instead of relying on systems to remain aligned, Circulo ensures alignment by design. Organizations gain real-time visibility, audit-ready data, and confidence that compliance is embedded into the process itself.
From Fragmentation to Orchestration
Pharma does not have a sampling problem. It has an orchestration problem.
Most organizations have digitized pieces of the process, but digitization alone does not create control. In many cases, it simply accelerates fragmentation.
The companies that will lead are not those with the most systems. They are the ones who control how those systems work together.
Because compliance does not live in any single system. It lives in the space between them.
And that is the part no one can afford to ignore anymore.
See What Your Process Actually Looks Like
If you’re not sure where your gaps are, you’re not alone. Most organizations don’t see them until they’re forced to.
We’ll walk through your current sampling workflow, identify where risk is introduced across systems and vendors, and show you what a fully orchestrated, audit-ready model looks like in practice.
Request a workflow assessment and platform demo and see where your process stands today.
